170 related articles for article (PubMed ID: 25628953)
1. Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis.
Dong ZR; Zhang PF; Wang CH; Zhang C; Cai JB; Shi GM; Ke AW; Sun HC; Qiu SJ; Zhou J; Fan J
Am J Cancer Res; 2015; 5(1):450-7. PubMed ID: 25628953
[TBL] [Abstract][Full Text] [Related]
2. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT.
Yin L; Li H; Li AJ; Lau WY; Pan ZY; Lai EC; Wu MC; Zhou WP
J Hepatol; 2014 Jul; 61(1):82-8. PubMed ID: 24650695
[TBL] [Abstract][Full Text] [Related]
3. Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria.
Li C; Wen TF; Yan LN; Lu WS; Li B; Wang WT; Xu MQ; Yang JY
J Surg Res; 2017 Mar; 209():8-16. PubMed ID: 28032575
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma.
Chen MY; Juengpanich S; Hu JH; Topatana W; Cao JS; Tong CH; Lin J; Cai XJ
World J Gastroenterol; 2020 Mar; 26(10):1042-1055. PubMed ID: 32205995
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
11. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
Ke Q; Xiang F; Xiao C; Huang Q; Liu X; Zeng Y; Wang L; Liu J
BMC Cancer; 2021 Oct; 21(1):1117. PubMed ID: 34663242
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study.
Zeng G; Zou B; Li Y; Lin E; Liu X; Li P; Chen J; Zhang B; Jia Y; Cai C; Li J
J Invest Surg; 2022 Jun; 35(6):1208-1216. PubMed ID: 35078386
[No Abstract] [Full Text] [Related]
13. Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy.
Ye TW; Wang DD; Lu WF; Xie YM; Xu FQ; Fu TW; Zhang KJ; Liu SY; Xie GL; Cheng J; Jiang K; Xiao ZQ; Yao WF; Shen GL; Liu JW; Huang DS; Zhang CW; Liang L
Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):395-403. PubMed ID: 36939280
[TBL] [Abstract][Full Text] [Related]
14. Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?
Lu Z; Wei X; Tan L; Xiang B; Gong W
Eur J Surg Oncol; 2023 Nov; 49(11):107073. PubMed ID: 37748278
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma.
Xie H; Tian S; Cui L; Yan J; Bai Y; Li X; Wang M; Zhang F; Duan F
Cancer Manag Res; 2019; 11():4065-4073. PubMed ID: 31118814
[No Abstract] [Full Text] [Related]
16. Treatment of hepatocellular carcinoma beyond the Milan criteria. A weighted comparative study of surgical resection versus chemoembolization.
Famularo S; Di Sandro S; Giani A; Bernasconi DP; Lauterio A; Ciulli C; Rampoldi AG; Corso R; De Carlis R; Romano F; Braga M; Gianotti L; De Carlis L
HPB (Oxford); 2020 Sep; 22(9):1349-1358. PubMed ID: 31932243
[TBL] [Abstract][Full Text] [Related]
17. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.
Wang H; Du PC; Wu MC; Cong WM
Hepatobiliary Surg Nutr; 2018 Dec; 7(6):418-428. PubMed ID: 30652086
[TBL] [Abstract][Full Text] [Related]
18. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
[TBL] [Abstract][Full Text] [Related]
20. Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study.
Wang Y; Ge H; Hu M; Pan C; Ye M; Yadav DK; Zheng R; Wu J; Sun K; Wang M; Tian Y; Huang J; Yao W; Li J; Zhang Q; Liang T
Int J Surg; 2022 Sep; 105():106852. PubMed ID: 36030036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]